← Leaderboards
Jessica B Kendrick
University Of Colorado Denver
$6,258,606
Attributed
$9,355,975
Total exposure
8
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.8M · FY2011–25$2M$1.5M$1M$500K$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$9,355,975 · 8
By mechanism
R01$5,654,830 · 3
T32$1,363,295 · 1
K23$783,860 · 1
TL1$664,393 · 1
R56$448,467 · 1
R21$441,130 · 1
Top collaborators
- Joshua M Thurman6 shared
- Richard Joseph Johnson5 shared
- Petter Bjornstad2 shared
- Alfred K. Cheung1 shared
- Keith B Neeves1 shared
Most similar at University Of Colorado Denver
Same institution · by research overlap
- Kerrie Moreau$13,944,323
- Gary L. Pierce$2,308,898
- Michel Benjamin Chonchol$9,752,858
- Joshua M Thurman$14,218,696
- Petter Bjornstad$9,008,713
Others in their field
Top investigators on “Kidney”
- Jeffrey P Krischer · University Of South Florida$540,222,210
- John M Lachin · George Washington University$155,894,464
- David M Nathan · Massachusetts Institute Of Technology$127,229,266
- Kathryn Hirst · Caritas St. Elizabeth'S Medical Center$111,521,899
- David Heimbrook · Leidos Biomedical Research, Inc.$83,221,586
- Peter Scott Heeger · Case Western Reserve University$80,562,246
Research focus
KidneyKidney DiseasesArterial StiffnessCardiovascular SystemCessation Of LifeRandomizedChronic Kidney FailureDouble-Blind MethodBlood VesselsCardiovascular DiseasesOralEndotheliumPlasmaVascular DiseasesMediatingBrachial ArteryProspectiveArteriesHypertensionClinical TrialsObservational StudyGeneral PopulationPlacebosMortality
Grant awards (25)
Mountain States Advancement in Research, Supportive Networking and Career Development (ASCEND)$664,393
TL1 · FY2025 · DK · contact PI
Efficacy and Mechanisms of Dapagliflozin in Promoting Kidney Function and Cardiovascular Health in Kidney Transplant Recipients$589,086
R01 · FY2025 · DK · contact PI
Effect of Alkali Therapy on Vascular and Graft Function in Kidney Transplant Recipients$543,870
R01 · FY2025 · DK · contact PI
Efficacy and Mechanisms of Dapagliflozin in Promoting Kidney Function and Cardiovascular Health in Kidney Transplant Recipients$665,824
R01 · FY2024 · DK · contact PI
Effect of Alkali Therapy on Vascular and Graft Function in Kidney Transplant Recipients$511,651
R01 · FY2024 · DK · contact PI
Renal and Electrolyte Disease and Hypertension$310,248
T32 · FY2024 · DK · contact PI
Effect of Alkali Therapy on Vascular and Graft Function in Kidney Transplant Recipients$532,971
R01 · FY2023 · DK · contact PI
Renal and Electrolyte Disease and Hypertension$265,561
T32 · FY2023 · DK · contact PI
Effect of Alkali Therapy on Vascular and Graft Function in Kidney Transplant Recipients$532,970
R01 · FY2022 · DK · contact PI
Renal and Electrolyte Disease and Hypertension$263,850
T32 · FY2022 · DK · contact PI
Evaluating the Association of Dietary Acid Load and Patterns with Cardiovascular Risk and Graft Histology in Kidney Transplant Recipients (KTRs) Across Race/Ethnicity$36,653
R01 · FY2022 · DK · contact PI
Effect of Alkali Therapy on Vascular and Graft Function in Kidney Transplant Recipients$532,560
R01 · FY2021 · DK · contact PI
Renal and Electrolyte Disease and Hypertension$262,920
T32 · FY2021 · DK
Bicarbonate Administration and Cognitive Function in Midlife and Older Adults with CKD$441,130
R21 · FY2020 · AG · contact PI
Bicarbonate Administration In CKD$423,376
R01 · FY2020 · HL · contact PI
Renal and Electrolyte Disease and Hypertension$260,716
T32 · FY2020 · DK
Bicarbonate Administration In CKD$423,376
R01 · FY2019 · HL · contact PI
Bicarbonate Administration In CKD$423,376
R01 · FY2018 · HL · contact PI
Bicarbonate Administration In CKD$439,117
R01 · FY2017 · HL · contact PI
Bicarbonate Administration in CKD$448,467
R56 · FY2016 · HL · contact PI
Vitamin D and Arterial Function in Patients with Chronic Kidney Disease$157,140
K23 · FY2015 · DK · contact PI
Vitamin D and Arterial Function in Patients with Chronic Kidney Disease$157,140
K23 · FY2014 · DK · contact PI
Vitamin D and Arterial Function in Patients with Chronic Kidney Disease$157,140
K23 · FY2013 · DK · contact PI
Vitamin D and Arterial Function in Patients with Chronic Kidney Disease$156,220
K23 · FY2012 · DK · contact PI
Vitamin D and Arterial Function in Patients with Chronic Kidney Disease$156,220
K23 · FY2011 · DK · contact PI